InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Wednesday, 03/27/2013 1:24:20 PM

Wednesday, March 27, 2013 1:24:20 PM

Post# of 40502
Everyone is also forgetting we have more Leukimia data this year in 2013. the trial for CML went well as 14 of 14 subjects had antibody responses to the leukimia with the inovio vaccine. So they went ahead and enrolled the Acute Myloid Leukimia arm patients(more severe to treat) and the results we shall see this year should be good. They will probably show BCR-ABL in CML and time to disease progression in AML possibly.

http://ir.inovio.com/2012-12-06-Inovio-Pharmaceuticals-Announces-Positive-Interim-Results-in-Phase-II-Leukemia-Trial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News